Claus Schmitzer is an accelerator technology engineer who was with the MedAustron project from very early stages on and accompanied the institution from architecture and layout phase up until successful patient treatment. He studied technical Physics at the Vienna University of Technology and graduated 2009 in experimental quantum optics. For his PhD he focused on plasma physics for ion source design in collaboration with CERN and spent 3 years working on Linac4 and SPL H- ion sources. In 2012 he joined the MedAustron project as a work package leader for the development and construction of synchrotron RF systems. Later he lead the Physics group including injector RF systems and ion sources. Since 2019 he supervises developments for all RF systems, vacuum systems, ion sources and beam instrumentation devices and represents MedAustron in several international collaborations.

Tim Schneider studied physics and high energy physics at ETH Zurich and École Polytechnique in Palaiseau and holds a PhD of Université Paris-Saclay for which he investigated the generation of magnetically focussed proton minibeams for radiation therapy. He is currently a post-doctoral researcher in the team „new approches in radiotherapy“ at the research centre of Institut Curie in Orsay. In his research, he works on the optimal implementation of proton minibeams in a clinical context and studies new application cases for X-ray minibeam radiation therapy.

PhD student from the University of Namur.

Dr. Schueler is Assistant Professor, Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. He is specializing in the development of novel treatment modalities and techniques to improve and expand the arsenal of cancer therapies. Currently, his research goals center on developing universal real-time dosimetry protocols for FLASH RT and characterizing the functional responses of normal and tumor tissues to FLASH irradiation with special emphasis towards elucidating the full scope of the FLASH effect physical parameters and oxygen dependence in both normal and tumor tissue.

Dr. Jan Schuemann is an Associate Professor within the department of Radiation Oncology at Massachusetts General Hospital and Harvard Medical School. Dr. Schuemanm is the Head of the Multi-Scale Monte Carlo Modeling Lab. His research focuses on understanding radiobiology from first principles. He is the PI of the TOPAS-nBio project, a nanometer scale extension of TOPAS, that simulates the physical and chemical damage induction and following repair kinetics. Dr. Schuemann’s lab applies mechanistic models in the design and analysis of our experiments. Currently, he leads the MGH efforts investigating the potential in vivo healthy tissue sparing effects for FLASH proton irradiations.

Dr. Andreas Schüller works as a scientist in the working group “Dosimetry for radiotherapy” of the Physikalisch-Technische Bundesanstalt in Braunschweig, the National Metrology Institute of Germany. He is the coordinator of the European Joint Research Project UHDpulse – Metrology for advanced radiotherapy using particle beams with ultra-high pulse dose rates.

Prof Seco graduated with a PhD from the University of London, at the Institute of Cancer Research (ICR) and Royal Marsden Hospital in London, UK. He then went on to become an Assistant Professor of Radiation Oncology at Harvard Medical School in Boston, working at the Massachusetts General Hospital (MGH). He then returned to Europe to work at the German Cancer Research Center, DKFZ in Heidelberg, heading up a new group dedicated to ion beam research and with the focus on 1) novel imaging technologies to reduce Bragg peak positioning errors in patients and 2) on investigating the mechanism of radiation triggered DNA damage via reactive oxygen species. He is also presently the Chair of Medical Physics at the Department of Physics and Astronomy, Heidelberg University and is a member of the EFOMP Scientific Committee, representing the DGMP, German Society for Medical Physics.

Dr. Sertorio is an Assistant Professor in the Radiation Oncology department at the University of Cincinnati College of Medicine. Dr. Sertorio developed the research area and activity at the UC/CCHMC Cincinnati proton center while enabling access and feasibility of new research project for multiple users. After serving as the Director of the Proton and Radiation Research Core service at CCHMC, he is now full time dedicated to research activity at the University of Cincinnati College of Medicine, focusing on development of new cancer therapy approaches based on photon and proton therapy (minibeam, FLASH) and tumor specific genetic/biologic features to improve cancer treatment (Head and neck squamous cell carcinoma, pancreas adenocarcinoma, medulloblastoma) outcome and radiation exposure toxicity (skin, soft tissue, brain neural progenitor cells). Development of new drugs and immunomodulatory strategies in combination with radiotherapy and translation of the results to the clinic are the main goals of his laboratory research activity.

Currently I am a 4th year PhD student at Insitut Curie and early stage researcher in the International network for training and innovation in therapeutic radiation (THERADNET). My conducted work focusses on examining the cellular and molecular consequences of AsiDNA in combination with FLASH radiotherapy on healthy tissues. More specifically, I am examining mechanisms driving resistance, and the possible protective effect of AsiDNA on normal tissue. https://theradnet.eu/early_stage_research/esr10-anouk-sesink/ https://www.linkedin.com/in/anouk-sesink-20a6a2138/